Tempest Therapeutics
Latest round
- Series B
Last raised
- Feb 2018
Total raised
- $40M
Investors
- 6
About Tempest Therapeutics
Tempest Therapeutics Inc.Founded in 2011, Tempest Therapeutics Inc. operates from South San Francisco, US, specializing in cancer treatment solutions. The company underwent a reverse merger with Millendo Therapeutics, Inc. in March 2021.Tempest Therapeutics specializes in developing first-in-class oral drug therapeutics aimed at addressing various cancer types, with a focus on targeted and immune-mediated therapies. Their flagship product, Amezalpat (TPST-1120), is designed to treat patients with hepatocellular carcinoma and has received Orphan Drug Designation from the European Medicines Agency.In the most recent fiscal year of 2017, Tempest Therapeutics generated revenue of USD 295,000, with an EBITDA of -USD 41,637,000.Tempest Therapeutics is focused on expanding its clinical pipeline and plans to launch new products aimed at enhancing its therapeutic offerings.00 mn to support these initiatives. The funds will facilitate the advancement of their primary product and the exploration of additional promising therapies, ensuring the company remains at the forefront of oncology treatment advancements.
Who invested in Tempest Therapeutics
6 investors across 2 rounds
See all investors in Tempest Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tempest Therapeutics
Who invested in Tempest Therapeutics?
Tempest Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tempest Therapeutics raised?
Tempest Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Tempest Therapeutics last raise money?
Tempest Therapeutics's most recent round on record is a Series B, in Feb 2018.
What does Tempest Therapeutics do?
Tempest Therapeutics is a biotechnology company.
Where is Tempest Therapeutics headquartered?
Tempest Therapeutics is headquartered in South San Francisco, US.
Which VCs invest in companies like Tempest Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tempest Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Tempest Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.